Medicinal Cannabis Matters – Friday Roundup 12th July

Medicinal Cannabis Matters | Friday roundup 12th July 2024.
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
This week, we explore the benefits older adults are experiencing from medicinal cannabis, Marisa Grech’s story as a medicinal cannabis patient, and the recall of cannabis products in California due to pesticide contamination.
Study shows that older adults see significant benefits from medicinal cannabis.
With the rise in medicinal cannabis use among adults over 65, a new study has found notable benefits for older patients. Participants reported on their quality of life, mood, and general health before starting medicinal cannabis and again three months later, showing significant improvements across all areas.
Medicinal cannabis Patient Marisa Grech shares her story.
After an accident at age 37, patient Marisa Grech was left with no flexibility in her spine, enduring severe pain and developing PTSD. She shares, “The difference between the two is that on morphine you’re just existing and on medical cannabis, you’re living”.
Read more about her story here
Cannabis products containing deadly pesticides recalled from California market.
The California Department of Cannabis Control has recalled five products from Five West Coast Cure due to the presence of Category 1 pesticides, including Chlorfenapyr. This highlights the importance of rigorous testing for medicinal cannabis, and at Medicann, we ensure that all products that we prescribe, strictly adhere to EUGMP standards to ensure safety and quality.
If you want to learn more about medicinal cannabis, and how it could help you better manage your condition, fill out the simple form linked below. To become a patient at the only award-winning clinic in Jersey and Guernsey take the first step today.
Check your eligibility.
https://www.medicann.co.uk/book-consultation/eligibility
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.